NCT05041699View on ClinicalTrials.gov

PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 20, 2022

Primary Completion Date

October 7, 2024

Study Completion Date

October 7, 2024

Conditions
PharmacokineticsSafety IssuesBleeding
Interventions
COMBINATION_PRODUCT

IPM Ring-105

DPV-LNG Ring containing xx mg of dapivirine + xx mg of levonorgestrel

COMBINATION_PRODUCT

IPM Ring-106

DPV-LNG Ring containing xx mg of dapivirine + xx mg of levonorgestrel

Trial Locations (2)

97239

Oregon Health & Science University, Portland

15213-3180

UPMC Magee-Womens Hospital, Center for Family Planning Research, Pittsburgh

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

International Partnership for Microbicides, Inc.

INDUSTRY